Short Gut Syndrome
7
1
2
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
28.6%
2 terminated out of 7 trials
0.0%
-86.5% vs benchmark
29%
2 trials in Phase 3/4
0%
2 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Clinical Trials (7)
Successful Fiber Food Introduction in Short Bowel Syndrome
Functional Sucrase Deficiency in Short Bowel Syndrome Patients With Intestinal Failure
Fiber Food Introduction in Pediatric Short Bowel Syndrome
Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC)
Innovative Central Line Securement Device in the Pediatric Population
A Phase III Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Investigational Product MP-101 in Subjects With Short Bowel Syndrome Who Have Had an Inadequate Response to Anti-Diarrheals
A Open Label Extension Study for Subjects That Complete Study MP-101-CL-001